The Compelling Case for GMP Investment

This spring, I’ve presented to over 150 industry professionals through events by ISPE, NCSL and Blue Mountain and have had interesting conversations with many of you.  The recurring theme of our conversations is that not only is the FDA raising the bar on GMP...